Change in Employee Representatives to the Board of Directors of Alligator Bioscience AB
Alligator Bioscience AB (publ) today announces that Tova Landström, PhD, Medical Science Director at Alligator, has been appointed as employ ...
Change in Employee Representatives to the Board of Directors of Alligator Bioscience AB
Laura von Schantz, employee representative, has resigned from the Alligator Bioscience AB Board of Directors, effective February 14, 2023, f ...
Alligator Bioscience Announces the Promotion of Laura von Schantz to Chief Technology Officer
Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces the promotion of Laura von Schantz to Chief Technology O ...
Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and Denise Goode
Lund, Sweden, May 9, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces the appointment of Staffan Encrantz and Den ...
Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer
Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), today announ ...
Board member in Alligator Bioscience resigns at his own request
Lund, Sweden, April 30, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company's Board member Carl Borre ...
Alligator Bioscience appoints Søren Bregenholt as new CEO
Lund, Sweden, March 18, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søre ...
Alligator Bioscience appoints Chief Scientific Officer
Lund, Sweden, January 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Peter Ellmark ...
Alligator Bioscience recruits new Chief Medical Officer
Lund, Sweden, December 29, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Christina ...